Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FU9GX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,999
Award facts
- Contract value 100% obligated
- $20,999.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,999.40 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. As a prime contractor on the DLA's comprehensive pharmaceutical support vehicle, the company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded without set-asides, demonstrating the company's capability to meet federal procurement standards. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, in which AmerisourceBergen may continue to participate alongside other contractors.
Quick answers
Who was awarded contract SPE2DB25FU9GX?
SPE2DB25FU9GX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FU9GX worth?
The government has obligated $20,999 on SPE2DB25FU9GX.
Is contract SPE2DB25FU9GX an order under another contract?
Yes. SPE2DB25FU9GX is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9GX competed?
The extent of competition for SPE2DB25FU9GX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award